MCh Neurosurgery: Admission, Medical School, Fees, Qualification Info

Published Date: 01 Mar 2023

Chirurgiae Master of Neurosurgery, also known as MCh Neurosurgery or MCh of Neurosurgery, is the highest level of training for doctors in India...

Read Full News

Latest News

NDAs Are Illegal in Healthcare, Says Ethicist

Ethicist Art Caplan discusses nondisclosure agreements in healthcare.

Whole-Body MRI Predicts Surgery Outcomes in Ovarian Cancer

Whole-body diffusion-weighted MRI accurately predicts complete resection and survival outcomes after neoadjuvant chemotherapy in patients with advanced ovarian cancer.

Some With Low-Grade Serous Ovarian Cancer May Not Need Chemo

A subgroup analysis hints that chemotherapy may be skipped after complete resection, but the finding needs further study.

MRI Sharpens Prostate Cancer Risk Stratification

A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to standard prognostic models to inform subsequent treatment.

Minimally Invasive Ablation Can Treat Small Kidney Tumors

Less invasive ablation treatment in patients with small renal tumors has a comparable risk for tumor progression to surgical resection, with fewer complications and shorter hospital stays.

177Lu-PSMA-617 Delays Progression in Prostate Cancer

177Lu-PSMA-617 delays disease progression at a significantly higher rate than standard of care in patients with oligometastatic hormone-sensitive prostate cancer.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Todays Updates

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

In a pilot study — the first to test CAR-T therapy in smoldering multiple myeloma — patients with high-risk disease remained MRD-negative for more than 15 months. But is it a cure?

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying specific cancers. Liquid biopsy could be next.

Dasatinib Fails to Improve Outcomes in CBF-AML

A phase 3 study investigates the outcomes associated with intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

A single-arm study hints at an uptick in pathologic complete responses when a CD39 blocker is added to perioperative durvalumab and chemotherapy for NSCLC.

Measurable Residual Disease Predicts Real-World AML Relapse

A study of a real-world population underscores measurable residual disease thresholds indicative of the risk for relapse in NPM1-mutated AML, suggesting guidance in treatment decisions.

Latest News

Ethicist Art Caplan discusses nondisclosure agreements in healthcare.

Whole-body diffusion-weighted MRI accurately predicts complete resection and survival outcomes after neoadjuvant chemotherapy in patients with advanced ovarian cancer.

A subgroup analysis hints that chemotherapy may be skipped after complete resection, but the finding needs further study.

A meta-analysis of nearly 25,000 patients undergoing radical prostatectomy supports adding presurgery MRI findings to standard prognostic models to inform subsequent treatment.

Less invasive ablation treatment in patients with small renal tumors has a comparable risk for tumor progression to surgical resection, with fewer complications and shorter hospital stays.

177Lu-PSMA-617 delays disease progression at a significantly higher rate than standard of care in patients with oligometastatic hormone-sensitive prostate cancer.

News All Time

Catholics May receive Organ Transplants From Animals, Vatican Says

The Vatican said on Tuesday that Catholics can receive transplants ⁠of animal tissues to address medical conditions, as procedures involving genetically modified pig or cow...

Lifelike 3D-Printed ‘Training Brains’ React Like Real Organs

Researchers create a new polymer that mimics the mechanical, thermal, and electromagnetic properties of brain tissue, driving new surgical and experimental uses.

Nerve Wrap Seen Speeding Erectile Recovery Post-Prostatectomy

Dehydrated human amniotic membrane appears promising in observational findings from a large dataset.

Stryker Cyberattack Delays Surgeries for Some Patients, Bloomberg News Reports

A cyberattack against medical device maker Stryker last ⁠week has delayed surgeries for some patients, Bloomberg News ⁠reported on Wednesday.

New Strategies Drive Success in Crohn’s Disease Care

In the management of Crohn’s disease, a key objective — preserving the bowel by reducing the need for multiple resections — is gaining ground.

Analysis-Middle East War Disrupts Pharma Air Routes, Risks Cancer Drugs Supply

War in the Middle East is disrupting the flow of critical medicines to the Gulf, imperilling supply routes for cancer drugs and other treatments that require refrigeration...

Does ADT Improve Survival After PORT in Prostate Cancer?

A meta-analysis explores whether there’s a survival benefit to adding hormone therapy to postoperative radiation for patients with low PSA levels.

Exercise and Lifestyle Help Manage Ankylosing Spondylitis

Evidence shows supervised exercise programs significantly improve function and quality of life in patients with axial spondyloarthritis.

Can Local Therapy Extend Life in Metastatic Breast Cancer?

For some women with de novo metastatic breast cancer, surgical resection of the primary tumor is associated with longer survival.

How to Talk to Your Patients About Exercise and Pain

Some are afraid to move if it hurts. Some push too hard. Everyone agrees that exercise reduces chronic pain and enhances health — but how do you keep patients on track?

CEM Matches MRI for Nipple-Areola Analysis in Breast Cancer

Contrast-enhanced mammography offers a reliable alternative to MRI in evaluating nipple-areola complex involvement in patients with breast cancer before surgery.

PSA May Predict Hormone Therapy Benefit Post-Prostatectomy

A meta-analysis seeks to determine if adding hormone therapy to radiotherapy after prostatectomy improves overall survival.

Life in the Endless Scroll: What We're Losing

What looks like harmless screen time may be altering emotional resilience and cognitive focus in young users.

Doc Pay Boosted $400 Million With New Medicare Billing Code

A new JAMA study shows that a new Medicare billing code may have benefited specialists more than the primary care physicians it was designed to help most.

MRI-Guided Chemotherapy Improves Survival in Breast Cancer

MRI-guided personalisation of neoadjuvant chemotherapy duration is associated with improved 3-year survival outcomes in patients with stage II-III HER2-positive breast cancer, a new trial reports.

NICE Backs Paperclip-Sized Sensor for Heart Failure Care

The CardioMEMS HF System enables daily home monitoring and has been shown to reduce hospital admissions in high-risk patients with chronic heart failure.

Recommended News For You

EVP Beats Cisplatin for Resectable MIBC

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

MRI-Guided TULSA Speeds Recovery vs Robotic Prostatectomy

Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.

'Dawson's Creek' Star Has Cancer; Radiotherapy Tattoos; Case of 'Petticoat' Cancer

CAR-T for Chronic Lymphocytic Leukemia Receives FDA Approval.

Extracellular matrix pathway emerges as treatment target for pediatric cancer

Recommended Articles For You

Exploring the Latest Treatments for Desmoid Tumors 

The Truth About Marijuana and Its Effect on Mental Health  

Advancing Cancer Trials: Integrating Master Protocols and Immunotherapy Guidelines 

Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How AI will transform mental health support for patients with breast cancer

2.

Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.

3.

PET-CT is better than contrast-enhanced CT as a predictor of survival in patients with metastatic breast cancer

4.

Routine MRI scans detect cancers in asymptomatic patients with rare genetic condition

5.

Nirogacestat is approved by the FDA for treating rare non-cancerous soft tissue sarcomas.

1.

Tazemetostat: A Promising New Treatment for Cancer

2.

Unlocking the Secrets of Oral Cancer Staging: A New Approach to Early Detection

3.

Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results

4.

Understanding Cold Agglutinin Disease: Symptoms, Diagnosis, and Treatment Options 

5.

The Latest Causes and Symptoms of Bowen's Disease: All You Need to Know 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

4.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

5.

Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot